Gabriela Kovacikova

MS Slovak Technical University


I use multiplexed high throughput assays to assess and/or support experimental clinical trials, ranging from phase I to phase III. Results from these studies help to evaluate safety and pharmacokinetics of newly design neutralizing antibodies and antibody response in disease states ranging from infection to cancer

I develop new protocols to increase reproducibility and efficiency of tests used in the dAbl lab, maintain lab proficiency and effectiveness, supporting research laboratory personel, and present research finding and progress at lab meetings and group meetings.

An important part of my work is maintaining a Good Clinical Laboratory Practices (GCLP) lab facility, which ensures the reproducibility of study results to the highest standards.